Stefanie Forderreuther
Overview
Explore the profile of Stefanie Forderreuther including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muller B, Gaul C, Reis O, Jurgens T, Kropp P, Ruscheweyh R, et al.
J Headache Pain
. 2024 Oct;
25(1):164.
PMID: 39354353
Background: Headache disorders are among the most prevalent neurological disorders worldwide. However, whether groups differing in socioeconomic position (SEP) are disproportionately affected by headache disorders has not yet been adequately...
2.
Ruscheweyh R, Forderreuther S, Freilinger T, Gaul C, Gossrau G, Patrick Jurgens T, et al.
Cephalalgia
. 2024 Jul;
44(7):3331024241261077.
PMID: 39033424
Background: The Migraine Disability Assessment (MIDAS) is widely used. However, there are limited data on how much a reduction in the MIDAS score indicates a change that matters to the...
3.
Gaul C, Forderreuther S, Lehmacher W, Weiser T
Front Neurol
. 2023 Nov;
14:1273846.
PMID: 37941578
Introduction: Observational studies are valuable for investigating correlations between patient-reported treatment outcomes. In this study, we report a secondary analysis of a published pharmacy-based observational (patient-centered "real-world" outcomes) study on...
4.
Ruscheweyh R, Gossrau G, Dresler T, Freilinger T, Forderreuther S, Gaul C, et al.
J Headache Pain
. 2023 Oct;
24(1):135.
PMID: 37817093
Background: Triptans are effective for many migraine patients, but some do not experience adequate efficacy and tolerability. The European Headache Federation (EHF) has proposed that patients with lack of efficacy...
5.
Engels D, Havla J, Forderreuther S, Kumpfel T
Mult Scler
. 2023 Sep;
29(14):1872-1875.
PMID: 37712413
Neuromyelitis optica spectrum disorder (NMOSD) in people living with HIV (PLWH) is rare and its management can be difficult. Here we report a case of an HIV patient with bilateral...
6.
Stormann S, Busygina K, Hein-Rothweiler R, Steffen J, Forderreuther S, Salein N, et al.
Clin Pract
. 2023 May;
13(3):616-620.
PMID: 37218807
We report the case of a 49-year-old male who suffered from a myocardial infarction with subsequent cardiac arrest. The emergency medical team began cardiopulmonary resuscitation, including defibrillation of ventricular fibrillation....
7.
Ruscheweyh R, Dresler T, Forderreuther S, Gaul C, Gossrau G, Patrick Jurgens T, et al.
Cephalalgia
. 2023 May;
43(5):3331024231174855.
PMID: 37177799
Background: Most migraine patients need an effective acute medication. Real-world data can provide important information on the performance of acute migraine medication in clinical practice. Methods: We used data from...
8.
Engels D, Mader S, Forderreuther S, Reindl M, Havla J, Meinl E, et al.
Ann Neurol
. 2023 Apr;
93(6):1216-1217.
PMID: 37089005
No abstract available.
9.
Muller B, Gaul C, Reis O, Jurgens T, Kropp P, Ruscheweyh R, et al.
J Headache Pain
. 2023 Apr;
24(1):37.
PMID: 37016306
Backgound: Headache disorders are not only among the most prevalent, they are also among the most disabling disorders worldwide. This paper investigates the association between headache impact on daily life...
10.
Gossrau G, Forderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, et al.
Schmerz
. 2023 Jan;
37(1):17-18.
PMID: 36662297
No abstract available.